Created in 2003 (United States), INFERGEN own
142 sister brands
and 17478 competing brands.
INFERGEN is owned by Amgen, listed on the stock exchange of New York
INFERGEN belongs to the Drug Manufacturers business sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.